Mastologia

FDA and EMA approval of datopotamab-deruxtecan: A paradigm shift in breast cancer drug evaluation?

Breast (Edinburgh, Scotland). 2025 Dec; 84(Dec):104589. doi: 10.1016/j.breast.2025.104589. pii: 104589.

Quantitative angiogenesis-based ultrasound biomarkers for differentiating radiologically challenging breast lesions: Radial scar vs invasive ductal carcinoma.

Breast (Edinburgh, Scotland). 2025 Dec; 84(Dec):104614. doi: 10.1016/j.breast.2025.104614. pii: 104614.

Differences in Treatment and Survival for Secondary Triple Negative Breast Cancer in Premenopausal Women.

Annals of surgical oncology. 2026 Jan; doi: 10.1245/s10434-025-18892-4. pii: .

Ten-Year Survival after Postmastectomy Chest-Wall Irradiation in Breast Cancer.

The New England journal of medicine. 2025 Nov; 393(Nov):1771-1783. doi: 10.1056/NEJMoa2412225. pii: .

Changes in patient management after preoperative MRI for newly diagnosed breast cancer: a multicentre prospective observational study.

The Medical journal of Australia. 2025 Dec; 223(Dec):602-610. doi: 10.5694/mja2.70051. pii: .

Imaging Surveillance and Risk-Based Management of Known Genetic Mutations in Breast Cancer: A Radiologist's Guide.

Journal of breast imaging. 2025 Dec; 7(Dec):636-652. doi: 10.1093/jbi/wbaf054. pii: .

Factors Associated With Residual Disease on Re-Excision Specimens After Breast-Conserving Surgery for Breast Cancer.

Annals of surgical oncology. 2025 Dec; doi: 10.1245/s10434-025-18813-5. pii: .

2024 EURAPS Expert Consensus on breast implant associated-anaplastic large cell lymphoma.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2025 Nov; 110(Nov):269-290. doi: 10.1016/j.bjps.2025.07.045. pii: S1748-6815(25)00527-3.

International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-low and Ultralow Categories.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2025 Oct; 100925. doi: 10.1016/j.modpat.2025.100925. pii: S0893-3952(25)00223-6.

ACR Appropriateness Criteria® Female Breast Cancer Screening: 2025 Update.

Journal of the American College of Radiology : JACR. 2025 Nov; 22(Nov):S508-S530. doi: 10.1016/j.jacr.2025.08.044. pii: S1546-1440(25)00498-3.

Pregnancy and Breast Cancer: Green-top Guideline No. 12.

BJOG : an international journal of obstetrics and gynaecology. 2025 Nov; 132(Nov):e194-e228. doi: 10.1111/1471-0528.18270. pii: .

American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions.

JAMA surgery. 2025 Oct; doi: 10.1001/jamasurg.2025.4392. pii: .

Recommendations From the Women's Preventive Services Initiative on Breast Cancer Screening for Women at Average Risk and Patient Navigation Services for Breast and Cervical Cancer Screening.

Obstetrics and gynecology. 2025 Jul; 146(Jul):315-322. doi: 10.1097/AOG.0000000000006011. pii: .

AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2025 Nov; 51(Nov):110445. doi: 10.1016/j.ejso.2025.110445. pii: S0748-7983(25)00873-X.

FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research. 2025 Nov; 31(Nov):4405-4411. doi: 10.1158/1078-0432.CCR-25-1388. pii: .

Consensus document on preoperative diagnostic procedures in breast lesions.

Pathologica. 2025 Jun; 117(Jun):178-198. doi: 10.32074/1591-951X-1113. pii: .

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025.

Breast care (Basel, Switzerland). 2025 Mar; 1-12. doi: 10.1159/000545018. pii: .

Age to Initiate Routine Breast Cancer Screening: ACOG Clinical Practice Update.

Obstetrics and gynecology. 2025 Jan; 145(Jan):e40-e44. doi: 10.1097/AOG.0000000000005757. pii: .

Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 1: The role of common errors in radiology in missed breast cancer and implications of misdiagnosis.

European radiology. 2024 Nov; doi: 10.1007/s00330-024-11128-1. pii: .

Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosis.

European radiology. 2024 Nov; doi: 10.1007/s00330-024-11133-4. pii: .

Tailoring neoadjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations.

Cancer. 2024 Oct; 130(Oct):3251-3271. doi: 10.1002/cncr.35389. pii: .

Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines.

Breast (Edinburgh, Scotland). 2024 Dec; 78(Dec):103806. doi: 10.1016/j.breast.2024.103806. pii: 103806.

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Aug; 34(Aug):645-659. doi: 10.1016/j.annonc.2023.05.008. pii: S0923-7534(23)00693-2.

Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.

Annals of surgical oncology. 2024 Sep; 31(Sep):5479-5482. doi: 10.1245/s10434-024-15638-6. pii: .

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).

Breast (Edinburgh, Scotland). 2024 Aug; 76(Aug):103756. doi: 10.1016/j.breast.2024.103756. pii: 103756.

Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Jul; 22(Jul):331-357. doi: 10.6004/jnccn.2024.0035. pii: .

Intensity Modulated Therapy for Patients With Breast Cancer. Practical Guidelines and Tips for an Effective Treatment Planning Strategy.

Advances in radiation oncology. 2024 Aug; 9(Aug):101535. doi: 10.1016/j.adro.2024.101535. pii: 101535.

Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline.

Practical radiation oncology. 2024 ; 14():112-132. doi: 10.1016/j.prro.2023.11.001. pii: S1879-8500(23)00296-5.

Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities.

Annals of surgical oncology. 2024 Oct; 31(Oct):7326-7334. doi: 10.1245/s10434-024-15713-y. pii: .

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Feb; 42(Feb):584-604. doi: 10.1200/JCO.23.02225. pii: .

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology. 2024 Feb; 35(Feb):159-182. doi: 10.1016/j.annonc.2023.11.016. pii: S0923-7534(23)05104-9.

Challenges of breast cancer screening.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2023 Sep; 45(Sep):551-554. doi: 10.1055/s-0043-1775931. pii: .

Challenges of breast cancer screening.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2023 Oct; 45(Oct):622-625. doi: 10.1055/s-0043-1776716. pii: .

Differences in Treatment and Survival for Secondary Triple Negative Breast Cancer in Premenopausal Women.

Annals of surgical oncology. 2026 Jan; doi: 10.1245/s10434-025-18892-4. pii: .

Menopausal hormone therapy for breast cancer patients: what is the current evidence?

Menopause (New York, N.Y.). 2026 Jan; 33(Jan):88-117. doi: 10.1097/GME.0000000000002627. pii: .

Safety of radiotherapy in patients undergoing breast reconstruction based on patient-reported outcomes: a multicenter collaborative study.

Breast cancer (Tokyo, Japan). 2025 Dec; doi: 10.1007/s12282-025-01815-2. pii: .

Imaging Surveillance and Risk-Based Management of Known Genetic Mutations in Breast Cancer: A Radiologist's Guide.

Journal of breast imaging. 2025 Dec; 7(Dec):636-652. doi: 10.1093/jbi/wbaf054. pii: .

Changes in patient management after preoperative MRI for newly diagnosed breast cancer: a multicentre prospective observational study.

The Medical journal of Australia. 2025 Dec; 223(Dec):602-610. doi: 10.5694/mja2.70051. pii: .

Factors Associated With Residual Disease on Re-Excision Specimens After Breast-Conserving Surgery for Breast Cancer.

Annals of surgical oncology. 2025 Dec; doi: 10.1245/s10434-025-18813-5. pii: .

Sentinel Lymph Node Biopsy for Prophylactic Mastectomy: Necessary Precaution or Unnecessary Procedure?

Annals of surgical oncology. 2025 Dec; doi: 10.1245/s10434-025-18814-4. pii: .

Quantitative angiogenesis-based ultrasound biomarkers for differentiating radiologically challenging breast lesions: Radial scar vs invasive ductal carcinoma.

Breast (Edinburgh, Scotland). 2025 Dec; 84(Dec):104614. doi: 10.1016/j.breast.2025.104614. pii: 104614.

FDA and EMA approval of datopotamab-deruxtecan: A paradigm shift in breast cancer drug evaluation?

Breast (Edinburgh, Scotland). 2025 Dec; 84(Dec):104589. doi: 10.1016/j.breast.2025.104589. pii: 104589.

Progress in surgical management strategies after neoadjuvant therapy in breast cancer.

Annals of medicine. 2025 Dec; 57(Dec):2559132. doi: 10.1080/07853890.2025.2559132. pii: 2559132.